International · XETRA: HIGH

Cantourage

Berlin, Germanycantourage.com
Profile in progress

Stock

Quotes and chart by TradingView; may be delayed.

About

Berlin-based importer, processor and distributor of medical cannabis that sources flower from growers in many countries and supplies German pharmacies, and is expanding into other European markets such as Poland and the UK. Also runs the Telecan telemedicine platform and is adding active-ingredient products for compounded prescriptions. Reported preliminary 2025 revenue of EUR 92.8 million.

Medical cannabisGermanyImport & distributionTelemedicineEU-GMPEurope

Leadership

Checked Oct 21, 2026
  • Chairman Christian SchreyerChairman of the Supervisory Boardcantourage.com
  • CEO Philip SchetterChairman of the Management Board (CEO) — departing; stays until successor appointedwebdisclosure.com
  • CFO Monique JaqqamChief Financial Officer (Member of the Management Board)cantourage.com
  • COO No COO on the published management board.
  • Investor Relations Manuel TaverneInvestor Relationscantourage.com

Other officers

  • Patrick HoffmannDeputy Chairman of the Supervisory Board
  • Bernhard RetzerVP Sourcing & Sales
  • Constanze PelzerVP Quality & Regulatory Affairs

Cantourage on IgniteIt

How we checked

Profile in progress

Still confirming: CEO successor and official logo. Last checked Oct 21, 2026.

  1. Ad hoc (10 Sep 2026): CEO Philip Schetter to leave early; successor search, he stays until replacedwebdisclosure.com
  2. Company team page: management board and supervisory board (Schreyer chair)cantourage.com
  3. IR page: HIGH ticker, Scale segment, IR contact, news through 19 Oct 2026cantourage.com
  4. Preliminary 2025 figures: revenue EUR 92.8Mboerse-online.de
  5. Dec 2025: Monique Jaqqam appointed CFOboerse-online.de
  6. TradingView XETR:HIGH confirms symboltradingview.com